What Are the Benefits of Microdosing? | Goop

Numinus's VP of Psychedelic Neurology, Dr. Evan Lewis, chats with  Kelly Martin from Goop to discu

Read More

Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoactive Fungi Species

Process leads to standardized psychedelic extracts that are reproducible, scalable, cost-effective a

Read More

Experts favour use of magic mushroom derivatives for research into mental health treatment

Educators, researchers see value in studying psilocybin’s effect treating mental health and addict

Read More

The business of producing psychedelics for science

The Daily Hive's Peter Smith speaks to Numinus CEO, Payton Nyquvest, about the business side of psyc

Read More

Numinus licensed by Health Canada to extract and research psilocybin

Numinus CEO, Payton Nyquvest, and Chief Operating Officer, Michael Tan, spoke to Mugglehead about an

Read More

Numinus Licencing Amendment: We Speak to the Team

Numinus Chief Operating Officer Michael Tan explains what the company's recent Health Canada licence

Read More

We want to connect with you!

Sign up here so we can keep in touch.